Phase I/IIa trial of AllerR ragweed allergy immunotherapy
Latest Information Update: 17 Apr 2015
At a glance
- Drugs AllerR (Primary)
- Indications Ragweed pollen hypersensitivity; Various toxicities
- Focus Adverse reactions; Therapeutic Use
- 01 Apr 2015 Planned initiation date changed from 1 Jan 2015 to 1 Jan 2016, according to an Anergis media release
- 13 Jun 2013 Planned initiation date changed from 1 Jan 2014 to 1 Jan 2015, based on information in an Anergis media release.
- 03 Mar 2013 New trial record